These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7895883

  • 21. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 22. [Peroxynitrite-induced formation of diabetic cataract and its prevention by puerarin in rat].
    Hao LN, Ling YL, He SZ, Mao QY, Liang JQ.
    Zhonghua Yan Ke Za Zhi; 2004 May; 40(5):311-6. PubMed ID: 15312625
    [Abstract] [Full Text] [Related]

  • 23. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 24. Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Lightman S.
    Eye (Lond); 1993 Apr; 7 ( Pt 2)():238-41. PubMed ID: 7607342
    [Abstract] [Full Text] [Related]

  • 25. Some effects of aldose reductase inhibition upon the eyes of long-term streptozotocin-diabetic rats.
    Poulsom R, Boot-Handford RP, Heath H.
    Curr Eye Res; 1993 Apr; 2(5):351-5. PubMed ID: 6819916
    [No Abstract] [Full Text] [Related]

  • 26. [Protection of polysaccharides-2b from mudan cortex of Paeonia suffruticosa andr on diabetic cataract in rats].
    Zhao GH, Shen YS, Ma JB, Li F, Shi XQ.
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2036-9. PubMed ID: 18161299
    [Abstract] [Full Text] [Related]

  • 27. Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
    Beyer-Mears A, Cruz E, Nicolas-Alexandre J, Varagiannis E.
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):166-76. PubMed ID: 6817723
    [Abstract] [Full Text] [Related]

  • 28. Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats.
    Abdul Nasir NA, Agarwal R, Sheikh Abdul Kadir SH, Vasudevan S, Tripathy M, Iezhitsa I, Mohammad Daher A, Ibrahim MI, Mohd Ismail N.
    PLoS One; 2017 Sep; 12(3):e0174542. PubMed ID: 28350848
    [Abstract] [Full Text] [Related]

  • 29. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D, Mirrlees DJ, Harrison HE, Earl DC.
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model.
    Grama CN, Suryanarayana P, Patil MA, Raghu G, Balakrishna N, Kumar MN, Reddy GB.
    PLoS One; 2013 Apr; 8(10):e78217. PubMed ID: 24155984
    [Abstract] [Full Text] [Related]

  • 31. [Magnetic resonance imaging study on rat sugar cataract].
    Mori K.
    Nippon Ganka Gakkai Zasshi; 1993 Oct; 97(10):1157-64. PubMed ID: 8256667
    [Abstract] [Full Text] [Related]

  • 32. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
    Gervasi GB, Bartoli C, Catalani R, Farina C, Carpita G, Caccia G, Ammannati P.
    Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
    [Abstract] [Full Text] [Related]

  • 33. Preventive effect of chlorogenic acid on lens opacity and cytotoxicity in human lens epithelial cells.
    Kim YS, Kim NH, Lee YM, Kim JS.
    Biol Pharm Bull; 2011 Nov; 34(6):925-8. PubMed ID: 21628897
    [Abstract] [Full Text] [Related]

  • 34. Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats.
    Ji L, Cheng L, Yang Z.
    J Diabetes Res; 2017 Nov; 2017():7309816. PubMed ID: 29038789
    [Abstract] [Full Text] [Related]

  • 35. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G, Leuenberger PM.
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [Abstract] [Full Text] [Related]

  • 36. Confirmation of lens hydration by Raman spectroscopy.
    Mizuno A, Toshima S, Mori Y.
    Exp Eye Res; 1990 Jun; 50(6):647-9. PubMed ID: 2115454
    [Abstract] [Full Text] [Related]

  • 37. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K.
    Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
    [No Abstract] [Full Text] [Related]

  • 38. [Slow development of rat sugar cataracts].
    Akagi Y, Tasaka H, Tanabe T, Yoshikawa T, Ikebe H, Chamoto K, Takahashi Y, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Jan; 91(1):122-6. PubMed ID: 2954440
    [No Abstract] [Full Text] [Related]

  • 39. Effect of nifedipine on severe experimental cataract in diabetic rats.
    Kametaka S, Kasahara T, Ueo M, Takenaka M, Saito M, Sakamoto K, Nakahara T, Ishii K.
    J Pharmacol Sci; 2008 Apr; 106(4):651-8. PubMed ID: 18431041
    [Abstract] [Full Text] [Related]

  • 40. [Reinvestigation of streptozotocin induced diabetic cataract as a standard experimental model].
    Kojima M, Sasaki K.
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):324-32. PubMed ID: 8317349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.